This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Celestra Life Science LLC. Active years: 2017-2019.
Location History:
- Richmond, VA (US) (2017)
- Richmond, NJ (US) (2019)
Company Filing History:
Years Active: 2017-2019
Title: David M Lu: Innovator in Targeted Cancer Therapies
Introduction
David M Lu is a notable inventor based in Richmond, NJ (US). He has made significant contributions to the field of cancer treatment through his innovative research and development. With a total of 2 patents, Lu is recognized for his work in targeted therapies that aim to improve patient outcomes.
Latest Patents
One of Lu's latest patents focuses on the rationale-based design of a targeted therapy for cancer. The methods, compositions, and kits of this invention are related to the discovery that lestaurtinib reduces levels and pathway activity of an SPOP substrate. Accordingly, the patent describes methods and compositions for the use of lestaurtinib in downregulating one or more SPOP substrates or signaling pathway activities in a subject in need thereof.
Career Highlights
David M Lu is currently associated with Celestra Life Science LLC, where he continues to advance his research in cancer therapies. His work is characterized by a commitment to developing effective treatment options that leverage the latest scientific discoveries.
Collaborations
Lu collaborates with talented individuals in his field, including coworkers Allen J Lee and Jason J Lee. Their combined expertise contributes to the innovative environment at Celestra Life Science LLC.
Conclusion
David M Lu's contributions to targeted cancer therapies exemplify the impact of innovation in medicine. His patents and ongoing research are paving the way for advancements in cancer treatment, ultimately benefiting patients in need.